EXPERTS-ALS is starting with repurposed drugs, but we are keen to rapidly develop industry partners to help them build confidence in human surrogate markers of benefit for their Phase 2 candidate drugs and so de-risk their Phase 3 investment.

If you are interested in becoming a partner, please get in touch by visiting our contact page